Showing results (41-50 of 60) with videos related to
Sort By:
Pageof 6
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|September 22, 2009
ACS-NSQIP has the potential to create an HPB-NSQIP optionHenry A Pitt, Molly Kilbane, Steven M Strasberg, et al.NMR in Biomedicine|September 10, 2014
HR-MAS MRS of the pancreas reveals reduced lipid and elevated lactate and taurine associated with early pancreatic cancerAlan S Wang, Alessia Lodi, Lee B Rivera, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 7, 2018
Lymph Node Ratio in Pancreatic Adenocarcinoma After Preoperative Chemotherapy vs. Preoperative Chemoradiation and Its Utility in Decisions About Postoperative ChemotherapyDouglas S Swords, Samual R Francis, Shane Lloyd, et al.Cancer Cell|April 13, 2011
Stat3 and MMP7 contribute to pancreatic ductal adenocarcinoma initiation and progressionAkihisa Fukuda, Sam C Wang, John P Morris, et al.The Journal of Clinical Investigation|July 3, 2002
Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotypeClive R Pullinger, Celeste Eng, Gerald Salen, et al.Neoplasia (New York, N.Y.)|July 23, 2021
Detection of circulating tumor DNA without a tumor-informed search using next-generation sequencing is a prognostic biomarker in pancreatic ductal adenocarcinomaKajsa E Affolter, Sabine Hellwig, David A Nix, et al.Pancreas|March 23, 2005
Transient receptor potential vanilloid (TRPV-1) promotes neurogenic inflammation in the pancreas via activation of the neurokinin-1 receptor (NK-1R)Matthew M Hutter, Elizabeth C Wick, Amy Lightner Day, et al.Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|September 13, 2006
Anti-inflammatory effects of PPAR-gamma agonists directly correlate with PPAR-gamma expression during acute pancreatitisMichael D Rollins, Sharon Sudarshan, Matthew A Firpo, et al.Surgery|September 2, 2018
Surgical overtreatment of pancreatic intraductal papillary mucinous neoplasms: Do the 2017 International Consensus Guidelines improve clinical decision making?Jeremy M Sharib, Annabelle L Fonseca, Douglas S Swords, et al.Nature Cell Biology|February 25, 2014
The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinomaGuido von Figura, Akihisa Fukuda, Nilotpal Roy, et al.Pageof 6